Literature DB >> 17452055

Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray.

Roger A Kroes1, Jeffrey Burgdorf, Nigel J Otto, Jaak Panksepp, Joseph R Moskal.   

Abstract

Gene expression profiles in the periaqueductal gray (PAG) of adult Long-Evans rats as a function of a stressful social defeat in inter-male fighting encounters were examined. This social subordination model mimics prototypical behavioral changes that parallel aspects of clinical depression, has been postulated to simulate early changes in the onset of depression in the losers, and has been successfully utilized for the evaluation of antidepressant activity. The 22-kHz ultrasonic vocalizations (USVs) have been shown to reflect negative emotional states akin to anxiety and depression. Social defeat is the most robust and reliable method of eliciting these calls. The PAG has been shown to be a key brain region for the generation of 22-kHz ultrasonic vocalizations, and 22-kHz USVs have been shown to be controlled by the mesolimbic cholinergic system. In this present study, we examined gene expression changes in the PAG of social subordinate rats compared to dominant rats that do not Exhibit 22-kHz USVs. We found that social defeat significantly altered the genes associated with cholinergic synaptic transmission in the PAG. The most robust of these were the increased expression of the beta2 subunit of the nicotinic acetylcholine receptor (CHRNB2) and the T subunit of acetylcholinesterase (ACHE) in the subordinate animals. These changes were corroborated by quantitative real-time polymerase chain reaction (qRT-PCR) and found to be exclusive to the PAG compared to seven other brain regions examined. These data suggest that cholinergic transmission in the PAG is involved in the generation of 22-kHz USVs and provide potential therapeutic targets for the treatment of affective disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452055      PMCID: PMC1993356          DOI: 10.1016/j.bbr.2007.03.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  78 in total

Review 1.  Pharmacological and behavioral characteristics of 22 kHz alarm calls in rats.

Authors:  S M Brudzynski
Journal:  Neurosci Biobehav Rev       Date:  2001-12       Impact factor: 8.989

2.  Depressive characteristics of FSL rats: involvement of central nicotinic receptors.

Authors:  Y Tizabi; A H Rezvani1; L T Russell; K Y Tyler; D H Overstreet
Journal:  Pharmacol Biochem Behav       Date:  2000-05       Impact factor: 3.533

3.  Anhedonia and motivational deficits in rats: impact of chronic social stress.

Authors:  Rafal Rygula; Nashat Abumaria; Gabriele Flügge; Eberhard Fuchs; Eckart Rüther; Ursula Havemann-Reinecke
Journal:  Behav Brain Res       Date:  2005-04-14       Impact factor: 3.332

Review 4.  Functional characteristics of the midbrain periaqueductal gray.

Authors:  M M Behbehani
Journal:  Prog Neurobiol       Date:  1995-08       Impact factor: 11.685

Review 5.  The periaqueductal gray and defensive behavior: functional representation and neuronal organization.

Authors:  P Carrive
Journal:  Behav Brain Res       Date:  1993-12-20       Impact factor: 3.332

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses.

Authors:  B M De Oca; J P DeCola; S Maren; M S Fanselow
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

Review 8.  Dominant-submissive behavior as models of mania and depression.

Authors:  Ewa Malatynska; Richard J Knapp
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

9.  Phosphorylated cyclic AMP response element binding protein expression induced in the periaqueductal gray by predator stress: its relationship to the stress experience, behavior and limbic neural plasticity.

Authors:  Robert E Adamec; Jacqueline Blundell; Paul Burton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-12       Impact factor: 5.067

Review 10.  Future prospects in depression research.

Authors:  Paul E Holtzheimer; Charles B Nemeroff
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more
  19 in total

1.  Regional changes in gene expression after limbic kindling.

Authors:  M E Corcoran; R A Kroes; J S Burgdorf; J R Moskal
Journal:  Cell Mol Neurobiol       Date:  2011-03-19       Impact factor: 5.046

2.  Increasing SK2 channel activity impairs associative learning.

Authors:  Bridget M McKay; M Matthew Oh; Roberto Galvez; Jeffrey Burgdorf; Roger A Kroes; Craig Weiss; John P Adelman; Joseph R Moskal; John F Disterhoft
Journal:  J Neurophysiol       Date:  2012-05-02       Impact factor: 2.714

Review 3.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

4.  Differential impact of a complex environment on positive affect in an animal model of individual differences in emotionality.

Authors:  J A Perez-Sepulveda; S B Flagel; M J Garcia-Fuster; R J Slusky; J W Aldridge; S Watson; H Akil
Journal:  Neuroscience       Date:  2013-06-24       Impact factor: 3.590

5.  Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.

Authors:  Barbara J Caldarone; Daguang Wang; Neil E Paterson; Michael Manzano; Allison Fedolak; Katie Cavino; Mei Kwan; Taleen Hanania; Sheela K Chellappan; Alan P Kozikowski; Berend Olivier; Marina R Picciotto; Afshin Ghavami
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

6.  22 kHz and 55 kHz ultrasonic vocalizations differentially influence neural and behavioral outcomes: Implications for modeling anxiety via auditory stimuli in the rat.

Authors:  Camila Demaestri; Heather C Brenhouse; Jennifer A Honeycutt
Journal:  Behav Brain Res       Date:  2018-12-03       Impact factor: 3.332

7.  Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder.

Authors:  Elizabeth L Berg; Nycole A Copping; Josef K Rivera; Michael C Pride; Milo Careaga; Melissa D Bauman; Robert F Berman; Pamela J Lein; Hala Harony-Nicolas; Joseph D Buxbaum; Jacob Ellegood; Jason P Lerch; Markus Wöhr; Jill L Silverman
Journal:  Autism Res       Date:  2018-01-29       Impact factor: 5.216

8.  Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Authors:  Jeffrey Burgdorf; Roger A Kroes; Xiao-lei Zhang; Amanda L Gross; Mary Schmidt; Craig Weiss; John F Disterhoft; Ronald M Burch; Patric K Stanton; Joseph R Moskal
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

Review 9.  A final common pathway for depression? Progress toward a general conceptual framework.

Authors:  Eric A Stone; Yan Lin; David Quartermain
Journal:  Neurosci Biobehav Rev       Date:  2007-10-10       Impact factor: 8.989

10.  Phasic dopamine release in the nucleus accumbens in response to pro-social 50 kHz ultrasonic vocalizations in rats.

Authors:  Ingo Willuhn; Amanda Tose; Matthew J Wanat; Andrew S Hart; Nick G Hollon; Paul E M Phillips; Rainer K W Schwarting; Markus Wöhr
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.